Ligand validation:6V94

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6V94_GOL_B_2008	70%	52%	0.119	0.935	0.87	1	-	-	0	0	100%	1
6V94_GOL_B_2007	65%	57%	0.112	0.914	0.81	0.84	-	-	0	0	100%	1
6D5H_GOL_B_2008	80%	88%	0.086	0.933	0.39	0.27	-	-	0	0	100%	1
6V9F_GOL_B_2007	79%	47%	0.106	0.951	1	1.03	-	-	1	0	100%	1
6D5E_GOL_B_2007	76%	81%	0.117	0.954	0.4	0.43	-	-	0	0	100%	1
6D55_GOL_B_2008	74%	41%	0.106	0.937	1.28	1.02	-	1	0	0	100%	1
6D5J_GOL_B_2008	74%	49%	0.103	0.933	0.91	1.04	-	1	0	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.